Ongoing conflict in the Middle East region has left thousands of families displaced in Lebanon, with an increase in food poverty, poor water sanitation and illness observed. MANCH ...
New consumer research reveals women and people with cycles spend an average of £20,359 on menstruating in their lifetime ; More than 1 in 3 (37%) of respondents struggle to affor ...
As medical students across the country learn where they will train during Match Day, ApolloMD is opening applications for its 2026 Emergency Medicine Scholarship. The annual award now provides $5,000 ...
Louvain‑la‑Neuve, Belgique, le 20 mars 2026 — IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et premier fournisseur mondial de solutions de p ...
Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-) breast cancer ; The lead ...
Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical ...
ALBANY, New York, 19 mars 2026 (GLOBE NEWSWIRE) -- Curia, acteur majeur de la recherche, du développement et de la fabrication sous contrat (CDMO), annonce ce jour la progression de l’extension de son ...
This Women's History Month, Lume Deodorant founder and lobular breast cancer survivor, Dr. Shannon Klingman, has made a historic $1 million gift to the Lobular Breast Cancer Alliance (LBCA) to fund ...
“Le quatrième trimestre a marqué notre premier trimestre complet de commercialisation aux États-Unis, et nous sommes très satisfaits de la forte dynamique que nous avons créée, qui nous a permis de dé ...
We finished 2025 with double-digit overall revenue growth in the fourth quarter with continued growth in our Canadian pharmaceutical business and sizable contributions from our international Tibelia ® ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results